Brief: GH Research Reports Q2 Loss Per Share Of $0.053
Sept 23 (Reuters) - GH Research PLC GHRS.O :
* PROVIDES BUSINESS UPDATES AND REPORTS SECOND QUARTER 2021
FINANCIAL RESULTS
* Q2 LOSS PER SHARE $0.053
* CASH WAS $292.6 MILLION AS OF JUNE 30, 2021, COMPARED TO
$5.9
MILLION AS OF DECEMBER 31, 2020
Source text for Eikon: ID:nGNX6vzYwT
Further company coverage: GHRS.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on GH Research
See all newsCorrected: UPDATE 2-Experts urge FDA to set clear safety and access standards for psychedelic drugs (September 14)
FDA to hold public hearing on psychedelic drugs as Trump-driven push gathers pace
Ireland's GH Research Q2 net loss widens on higher R&D costs
AtaiBeckley surges after report Lilly poised to buy psychedelic drug developer
Street View: Psychedelic sector gains after report Lilly nears AtaiBeckley acquisition